Ex Parte Amos et alDownload PDFPatent Trials and Appeals BoardJun 17, 201914623264 - (D) (P.T.A.B. Jun. 17, 2019) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 14/623,264 02/16/2015 121974 7590 06/19/2019 KACVINSKY DAISAK BLUNI PLLC America's Cup Building 50 Doaks Lane Marblehead, MA 01945 FIRST NAMED INVENTOR Michael Devon Amos UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 8150BSC0480Cl 4834 EXAMINER WENG,KAIH ART UNIT PAPER NUMBER 3781 NOTIFICATION DATE DELIVERY MODE 06/19/2019 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): bbonneville@kdbfirm.com docketing@kdbfirm.com ehysesani@kdbfirm.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte MICHAEL DEVON AMOS, JOHN LANE, JACOB GRAHAM, GARY J. LEANNA, ANDREW K. HOLLETT, and MICHAL WEISMAN Appeal2018-009192 1 Application 14/623,2642 Technology Center 3700 Before PHILIP J. HOFFMANN, BRADLEYB. BAY AT, and ROBERT J. SILVERMAN, Administrative Patent Judges. BAY AT, Administrative Patent Judge. DECISION ON APPEAL Appellants appeal under 35 U.S.C. § 134(a) from Examiner's final rejection of claims 1-20, which are all the pending claims in the application. We have jurisdiction under 35 U.S.C. § 6(b). We reverse. 1 Our Decision references Appellants' Appeal Brief ("Appeal Br.," filed Apr. 2, 2018) and Reply Brief ("Reply Br.," filed Sept. 26, 2018), and the Examiner's Answer ("Ans.," mailed July 26, 2018) and Final Office Action ("Final Act.," mailed Nov. 2, 2017). 2 Appellants identify "Boston Scientific Scimed, Inc." as the real party in interest. Appeal Br. 2. Appeal2018-009192 Application 14/623,264 STATEMENT OF THE CASE Claimed Subject Matter Appellants' "disclosure is directed to a stent retention structure for selectively securing a stent to a shaft of a drainage stent delivery system." Spec. 1 :8-9. Claim 1, reproduced below with added bracketed matter, is illustrative of the subject matter on appeal. 1. A stent delivery system comprising: [ (a)] a drainage stent having a proximal end, a distal end, and lumen extending therethrough, [ (b)] the drainage stent including a tab extending radially inward into the lumen from a tubular wall of the drainage stent; and [ ( c)] an elongate shaft extending distally from a handle assembly, [(d)] the elongate shaft having a distal end portion extending into the lumen of the drainage stent; [ ( e)] wherein the tab is configured to mate with an opening in the distal end portion of the elongate shaft to selectively couple the drainage stent to the elongate shaft. Appeal Br. 14, Claims App. Rejection Examiner rejected claims 1-20 under 35 U.S.C. § I02(b) as being anticipated by Goto et al. (US 2005/0085891 Al, pub. Apr. 21, 2005) ("Goto"). Final Act. 2-5. ANALYSIS Anticipation of claims 1-20 by Goto Examiner maintains that claims 1-20 are anticipated by Goto because Goto discloses each and every element of Appellants' claimed invention. See Ans. 2--4. Goto "relates to a stent delivery device which is used in combination with an endoscope to insert a stent into a body cavity of a 2 Appeal2018-009192 Application 14/623,264 patient and place it there." Goto ,r 4. Figure IA of Goto is reproduced below: Figure IA of Goto depicts an embodiment of a stent delivery device in an engagement stage, which includes a stent 14, a pusher tube 15, a guide catheter cock 13 at the proximal end of a guide catheter 11, a pusher tube cock 18 at the proximal end of the pusher tube 15, and an engagement member 21 at the distal end of a linear member 20 led out of the lumen of the pusher tube 15 and brought into engagement with an engagement depression 17. Id. ,r,r 43--45, 47, 53. Goto' s Figure 9B is reproduced below: 14 11 19 \ 17 { ."':>':~ .... .... ' ..• ' ..... ~' FIG,9B n Figure 9B depicts another embodiment of a stent delivery device in an engagement state, which includes a guide catheter 11 that is rotatable on its longitudinal axis inside of stent 14 and pusher tube 15. Goto ,r,r 90, 93. In this embodiment, opening 22 is formed in the circumferential wall of the guide catheter 11, and the engagement member 21 can drop into the opening 22. The opening is in the plane which is substantially perpendicular to the central axis of the stent and which passes 3 Appeal2018-009192 Application 14/623,264 the engagement depression 17. With this structure, the engagement member 21 drops into the opening 22 by slightly rotating the guide catheter 11. In this manner, the stent 14 and the engagement member 21 are disengaged from each other. Id. ,T 93. In rejecting independent claim 1, Examiner finds: Goto discloses a drainage stent ( 14 & 15) having a proximal end, distal end, and a lumen extending therethrough (figure IA), the drainage stent including a tab (21) extending radially inward into the lumen from a tubular wall of the stent (the tab is attached to tube 15, figure 9B), an elongated shaft (11) extending distally from a handle assembly (13 & 18[, figure 9B]), the distal portion of the shaft is inside of the lumen of the stent (figure 9B), the tab is configured to mate with an opening (22) in the distal end of the shaft to couple the stent to the shaft ([0093]). Final Act. 3; Ans. 2. In particular, Examiner cites Figure IA of Goto as disclosing elements (a) and (c), and Figure 9B of Goto as disclosing elements (b ), ( d), and ( e) of claim 1. We find Examiner improperly relies upon different embodiments of Goto to disclose elements recited in claim 1. It is well-settled that [ s ]uch picking and choosing may be entirely proper in the making of a 103, obviousness rejection, where the applicant must be afforded an opportunity to rebut with objective evidence any inference of obviousness which may arise from the similarity of the subject matter which he claims to the prior art, but it has no place in the making of a 102, anticipation rejection. Application of Arkley, 455 F.2d. 586, 587-88 (CCPA 1972); see also Net MoneyIN, Inc. v. VeriSign, Inc., 545 F.3d 1359, 1371 (2008) ("Thus, it is not enough that the prior art reference ... includes multiple, distinct teachings 4 Appeal2018-009192 Application 14/623,264 that the artisan might somehow combine to achieve the claimed invention."; citation to Arkley omitted). As such, Examiner fails to demonstrate that Goto discloses, in a single embodiment, each and every element of claim 1, as set forth in the claim. See Verdegaal Bros., Inc. v. Union Oil Co. of Cal., 814 F .2d 631 (Fed. Cir. 1987). Similarly, Examiner selects elements from embodiments of Goto's Figures IA and 9B in order to meet the limitations of independent claims 9 and 14. See Final Act. 4; see also Ans. 3--4. Because Examiner has failed to establish a prima facie case of anticipation, we do not sustain the rejection of independent claims 1, 9, and 14 as anticipated by Goto, including claims 2-8, 10-13, and 15-20 dependent thereon. DECISION The rejection of claims 1-20 under 35 U.S.C. § I02(b) is reversed. REVERSED 5 Copy with citationCopy as parenthetical citation